Inflammation and pancreatic ductal adenocarcinoma: a potential scenario for novel drug targets

JOP. 2010 May 5;11(3):199-202.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antioxidants / therapeutic use*
  • Carcinoma, Pancreatic Ductal / drug therapy*
  • Cyclooxygenase 2 Inhibitors / therapeutic use*
  • Humans
  • NF-kappa B / antagonists & inhibitors
  • PPAR gamma / antagonists & inhibitors
  • Pancreatic Neoplasms / drug therapy*
  • Pancreatitis / drug therapy*

Substances

  • Antioxidants
  • Cyclooxygenase 2 Inhibitors
  • NF-kappa B
  • PPAR gamma